Homeopathic Drug Product Regulation

Current understanding

Homeopathic drug products have historically occupied an ambiguous space in FDA regulation, marketed without the premarket approval or standardized manufacturing controls required for conventional drugs. Legislation in the 119th Congress (Homeopathic Drug Product Safety, Quality, and Transparency Act) proposes to establish explicit safety, quality, and transparency requirements for these products. Status: introduced in the Senate and referred to the HELP Committee.

Evidence log

• 2026-01-14 — Homeopathic Drug Product Safety, Quality, and Transparency Act: 2026-01 — Homeopathic Drug Product Safety, Quality, and Transparency Act (HR7050) introduced and referred to House Energy and Commerce Committee; would establish statutory safety, quality, and transparency requirements for homeopathic drug products under FDA oversight. (novelty: 2)

Open questions

Related